Princeton, New Jersey, March 31, 2015 – Sandoz today announced the US market introduction of amlodipine and valsartan combination tablets, a generic version of EXFORGE® made by Novartis.Amlodipine and valsartan tablets are a combination of amlodipine, …
Princeton, New Jersey, March 31, 2015 – Sandoz today announced the US market introduction of amlodipine and valsartan combination tablets, a generic version of EXFORGE® made by Novartis.Amlodipine and valsartan tablets are a combination of amlodipine, …
Sandoz launches 50-250 and 50-500µg dosage forms in Portugal and IrelandInnovative inhaler offers asthma and COPD patients a new therapeutic optionNow available to patients in 14 countries, as global roll-out continues apaceHolzkirchen, March 11, 2015 …
Sandoz launches 50-250 and 50-500µg dosage forms in Portugal and IrelandInnovative inhaler offers asthma and COPD patients a new therapeutic optionNow available to patients in 14 countries, as global roll-out continues apaceHolzkirchen, March 11, 2015 …
Sandoz is the first company to receive approval of a biosimilar in the US through the new FDA biosimilars pathway established under BPCIAZarxio is approved for all indications included in the reference product’s (NEUPOGEN®) labelApproval paves way for …
Sandoz is the first company to receive approval of a biosimilar in the US through the new FDA biosimilars pathway established under BPCIAZarxio is approved for all indications included in the reference product’s (NEUPOGEN®) labelApproval paves way for …
Completes transactions with GSK including: acquisition of GSK oncology portfolio, creation of Consumer Healthcare joint venture, and sale of non-influenza Vaccines businessSharpens company focus on growing segments of innovative pharmaceuticals, eye ca…
Approximately 400 mothers and newborns die in Ethiopia each day1,2 partly due to health workers’ limited knowledge in the area of obstetricsEnhancing medical knowledge and skills of health workers helps reduce maternal and newborn mortalitySandoz is co…
February 04, 2015 – Between 160,000 and 200,000 children are estimated to be diagnosed with childhood cancer and around 100,000 die from it each year. With proper diagnosis, treatment and drugs, most childhood cancers can be cured. In the developed cou…
Basel, January 27, 2015 – Commenting on the results, Joseph Jimenez, CEO of Novartis, said: “2014 was a transformational year for Novartis. We improved our execution, while taking steps to focus the company on our three leading businesses with global s…